Allowing countries to use PEPFAR funding for voluntary contraception for women aligns with GHI's 'women-centered' approach

NewsGuard 100/100 Score

"PEPFAR has said it will use" nearly $1.5 billion in unspent aid "to invest in commodities (condoms, HIV rapid test kits and voluntary medical male circumcision kits), systems and institutions, and program strengthening," Suzanne Ehlers, president of Population Action International, writes in this post in the Huffington Post's "Impact" blog. "Here's one idea that would offer a huge return on investment and save the lives of millions: voluntary contraception for women," she continues, adding, "Voluntary contraception has been called 'the best kept secret in HIV prevention' and has a proven evidence base."

"Access to contraception has long been identified as one of four key components of successful programs  to prevent mother-to-child transmission (PMTCT) of HIV, and yet it has been neglected because of insufficient resources and separate funding streams," Ehlers writes, noting, "New World Health Organization guidelines on couples HIV testing and counseling include family planning as part of the package of information and linked services offered in counseling sessions." She adds, "All women, including those living with HIV, have a right to decide whether and when to have children, and how many to have," and concludes, "We should allow countries to use PEPFAR funds for contraceptives beyond condoms, as well as health workforce training to deliver integrated family planning and HIV services and supply chain strengthening to prevent stock-outs. This would also align with the Global Health Initiative's [GHI] aim of a more integrated, women-centered and country-driven global health program" (4/24).


http://www.kaiserhealthnews.orgThis article was reprinted from kaiserhealthnews.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
New review aims to help clinicians diagnose and manage PCOS